As of 2026-03-25, the EV/EBITDA ratio of Clearpoint Neuro Inc (CLPT) is -12.31. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CLPT's latest enterprise value is 271.23 mil USD. CLPT's TTM EBITDA according to its financial statements is -22.04 mil USD. Dividing these 2 quantities gives us the above CLPT EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 16.4x - 18.7x | 17.2x |
| Forward P/E multiples | 19.1x - 22.2x | 21.7x |
| Fair Price | (13.86) - (13.52) | (14.10) |
| Upside | -247.1% - -243.5% | -249.7% |
| Date | EV/EBITDA |
| 2026-03-23 | -12.43 |
| 2026-03-20 | -11.78 |
| 2026-03-19 | -11.98 |
| 2026-03-18 | -12.56 |
| 2026-03-17 | -14.66 |
| 2026-03-16 | -14.48 |
| 2026-03-13 | -14.16 |
| 2026-03-12 | -15.16 |
| 2026-03-11 | -15.28 |
| 2026-03-10 | -14.87 |
| 2026-03-09 | -15.17 |
| 2026-03-06 | -13.09 |
| 2026-03-05 | -12.08 |
| 2026-03-04 | -11.66 |
| 2026-03-03 | -11.52 |
| 2026-03-02 | -12.82 |
| 2026-02-27 | -16.56 |
| 2026-02-26 | -19.07 |
| 2026-02-25 | -20.06 |
| 2026-02-24 | -19.23 |
| 2026-02-23 | -19.52 |
| 2026-02-20 | -18.69 |
| 2026-02-19 | -18.96 |
| 2026-02-18 | -18.75 |
| 2026-02-17 | -17.92 |
| 2026-02-13 | -17.88 |
| 2026-02-12 | -17.19 |
| 2026-02-11 | -17.64 |
| 2026-02-10 | -17.94 |
| 2026-02-09 | -18.64 |
| 2026-02-06 | -17.76 |
| 2026-02-05 | -16.56 |
| 2026-02-04 | -17.56 |
| 2026-02-03 | -18.41 |
| 2026-02-02 | -17.46 |
| 2026-01-30 | -17.05 |
| 2026-01-29 | -17.71 |
| 2026-01-28 | -17.72 |
| 2026-01-27 | -19.02 |
| 2026-01-26 | -18.76 |
| 2026-01-23 | -20.76 |
| 2026-01-22 | -18.77 |
| 2026-01-21 | -18.50 |
| 2026-01-20 | -18.35 |
| 2026-01-16 | -19.37 |
| 2026-01-15 | -19.37 |
| 2026-01-14 | -20.39 |
| 2026-01-13 | -19.12 |
| 2026-01-12 | -20.72 |
| 2026-01-09 | -19.73 |